Morbidity in patients on l‐thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH
- 1 December 1992
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 37 (6), 500-503
- https://doi.org/10.1111/j.1365-2265.1992.tb01480.x
Abstract
Patients on L-thyroxine with a 'suppressed' TSH (< 0.05 mU/l) were compared to those in whom TSH was detectable but not elevated (0.05-4.0 mU/l), with regard to morbidity data. Biochemical data from Tayside Thyroid Register was matched to hospital admissions data obtained from Health Board Statistics. The patients were identified from those registered on the computerized Tayside Register. Serum T4 and TSH assays, clinical assessment scores, and admission records with regard to ischaemic heart disease, overall fractures, fractured neck of femur and breast carcinoma. Over one year, 1180 patients on thyroxine replacement had clinical and biochemical assessment; 59% had a suppressed TSH and 38% 'normal' TSH. Patients with a suppressed TSH exhibited higher median serum thyroxine levels (146 nmol/l, range 77-252 vs 119 nmol/l, 58-224; P < 0.001). Patients under the age of 65 years on L-thyroxine had an increased risk of ischaemic heart disease compared to the general population (female 2.7 vs 0.7%, P < 0.001; male 6.4 vs 1.7%, P < 0.01), but the risk was no different between those with suppressed and normal TSH. There was no increase in risk for overall fracture, fractured neck of femur or breast carcinoma in those on thyroxine with suppressed or normal TSH. Patients under the age of 65 years on L-thyroxine had an increased risk of ischaemic heart disease. There was no excess of fractures in patients on L-thyroxine even if the TSH is suppressed.Keywords
This publication has 18 references indexed in Scilit:
- Long-term thyroxine treatment and bone mineral densityThe Lancet, 1992
- Thyroxine replacement therapyThe Lancet, 1991
- THYROXINE REPLACEMENT THERAPY—TOO MUCH OF A GOOD THING?The Lancet, 1990
- Morbidity, mortality, and quality of life for patients treated with levothyroxineArchives of Internal Medicine, 1990
- BONE MINERAL DENSITY AND THYROID HORMONE THERAPYClinical Endocrinology, 1990
- Health checks for adults.BMJ, 1990
- Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit.BMJ, 1988
- Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal womenPublished by American Medical Association (AMA) ,1988
- FINE ADJUSTMENT OF THYROXINE REPLACEMENT DOSAGE: COMPARISON OF THE THYROTROPHIN RELEASING HORMONE TEST USING A SENSITIVE THYROTROPHIN ASSAY WITH MEASUREMENT OF FREE THYROID HORMONES AND CLINICAL ASSESSMENTClinical Endocrinology, 1988
- LDL/HDL‐CHANGES IN SUBCLINICAL HYPOTHYROIDISM: POSSIBLE RISK FACTORS FOR CORONARY HEART DISEASEClinical Endocrinology, 1988